TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | -1 | 3 | -2 | -20 | -18 | -24 | -10 |
| S | %wins | 83 | 33 | 50 | 67 | 83 | 100 | 69 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/1/18 17:24 | 2/28/18 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -599 | 25.01 | 0 | -24 | -93 | 2 | D | ||||||||||||||
10/5/16 16:49 | 10/3/16 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -182 | 29.28 | 7 | -6 | -76 | 2 | D | 38 | 28 | 36 | 11 | -7 | 1 | -7 | -1 | -1 | -2 | -28 | -34 | -43 | |
7/6/16 20:43 | 7/1/16 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -243 | 27.22 | 8 | -9 | -82 | 2 | D | 18 | -29 | -11 | 35 | 16 | 4 | -1 | -3 | -1 | 5 | 21 | 13 | -24 | |
5/27/16 14:32 | 5/27/16 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -125 | 25.00 | 7 | -5 | -72 | 2 | D | 23 | -25 | -30 | 51 | 8 | 32 | 33 | 6 | 2 | 10 | -4 | 22 | 17 | |
11/24/15 15:32 | 11/23/15 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -242 | 35.00 | 8 | -7 | -78 | 2 | D | 59 | 28 | 9 | 37 | 38 | 6 | 10 | 2 | -1 | -1 | -10 | -56 | -30 | -22 |
7/1/15 16:28 | 7/1/15 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -257 | 37.15 | 10 | -7 | -64 | 4 | D | 75 | 6 | 21 | 19 | 19 | 4 | 4 | 0 | 1 | 5 | -38 | -10 | -22 | |
6/16/15 13:28 | 6/15/15 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Cilinski Lynn | MD | O | VP,Contr | S.d | -375 | 35.00 | 6 | -11 | -65 | 6 | D | 64 | 19 | 1 | 19 | 10 | 8 | 11 | -3 | 7 | 3 | -24 | -16 | -28 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |